BIO-REFERENCE LABS INC-NEW-
BRLI
BRLI was delisted on the 19th of August, 2015.
175 hedge funds and large institutions have $793M invested in BIO-REFERENCE LABS INC-NEW- in 2013 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 66 increasing their positions, 60 reducing their positions, and 23 closing their positions.
10% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 60
3% more call options, than puts
Call options by funds: $14.1M | Put options by funds: $13.7M
1% more capital invested
Capital invested by funds: $784M → $793M (+$8.86M)
3% less funds holding
Funds holding: 181 → 175 (-6)
22% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$11.7M |
| 2 |
CM
CS McKee
Pittsburgh,
Pennsylvania
|
+$11.1M |
| 3 |
LSV Asset Management
Chicago,
Illinois
|
+$7.09M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$5.48M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.42M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$21.1M |
| 2 |
RIM
Rainier Investment Management
Seattle,
Washington
|
-$16M |
| 3 |
Jennison Associates
New York
|
-$6.04M |
| 4 |
CPIM
Columbia Partners Investment Management
Alexandria,
Virginia
|
-$5.27M |
| 5 |
RFC
Russell Frank Company
Seattle,
Washington
|
-$3.92M |
BRLI Hedge Fund Activity: Q3 2013 in Review
175 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in BIO-REFERENCE LABS INC-NEW- (BRLI) for Q3 2013, worth a combined $793M — up 1.1% from $784M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of BRLI and 18 opened new positions — a net loss of 5 holders — while 60 trimmed existing stakes and 66 added.
The largest buyer was Manulife (Manufacturers Life Insurance), adding an estimated $11.7M. The largest seller was Champlain Investment Partners, exiting entirely with an estimated $21.1M sold.
- 175 institutional investors held BIO-REFERENCE LABS INC-NEW- (BRLI) as of Q3 2013, down from 181 in Q2 2013.
- Funds reported $793M of BIO-REFERENCE LABS INC-NEW- stock for Q3 2013, up 1.1% quarter-over-quarter.
- 18 funds opened new BIO-REFERENCE LABS INC-NEW- positions in Q3 2013 and 23 closed out, a net change of -5 holders.
- The largest BIO-REFERENCE LABS INC-NEW- buyer in Q3 2013 was Manulife (Manufacturers Life Insurance), an estimated $11.7M added.
- The largest BIO-REFERENCE LABS INC-NEW- seller in Q3 2013 was Champlain Investment Partners, an estimated $21.1M sold.
Based on aggregated 13F filings for Q3 2013.